Andrews, K. A., Modat, M., Macdonald, K. E., Yeatman, T., Cardoso, M. J., Leung, K. K., . . . Schott, J. M. (2013). Atrophy Rates in Asymptomatic Amyloidosis: Implications for Alzheimer Prevention Trials. PLoS ONE, 8(3), 1. https://doi.org/10.1371/journal.pone.0058816
Chicago Style (17th ed.) CitationAndrews, K. Abigail, et al. "Atrophy Rates in Asymptomatic Amyloidosis: Implications for Alzheimer Prevention Trials." PLoS ONE 8, no. 3 (2013): 1. https://doi.org/10.1371/journal.pone.0058816.
MLA (9th ed.) CitationAndrews, K. Abigail, et al. "Atrophy Rates in Asymptomatic Amyloidosis: Implications for Alzheimer Prevention Trials." PLoS ONE, vol. 8, no. 3, 2013, p. 1, https://doi.org/10.1371/journal.pone.0058816.
Warning: These citations may not always be 100% accurate.